We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.45B
AUM Growth
-$493M
Cap. Flow
+$322M
Cap. Flow %
5.9%
Top 10 Hldgs %
20.77%
Holding
587
New
179
Increased
113
Reduced
93
Closed
156

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.94%
2 Industrials 14.9%
3 Consumer Discretionary 13.15%
4 Financials 9.17%
5 Technology 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
276
DELISTED
Alexion Pharmaceuticals
ALXN
$1.39M 0.03%
+10,010
New +$1.47M
PARA
277
DELISTED
Paramount Global Class B
PARA
$1.38M 0.03%
25,000
-105,000
-81% -$5.11M
CRZO
278
DELISTED
Carrizo Oil & Gas Inc
CRZO
$1.37M 0.03%
44,375
+375
+0.9% +$9.45K
DVAX
279
DELISTED
Dynavax Technologies
DVAX
$1.35M 0.02%
70,000
+60,000
+600% +$1.21M
NOW icon
280
ServiceNow
NOW
$121B
$1.32M 0.02%
+107,750
New +$1.36M
GPOR
281
DELISTED
Gulfport Energy Corp.
GPOR
$1.3M 0.02%
45,993
-104,807
-70% -$2.77M
TXMD icon
282
TherapeuticsMD
TXMD
$24.2M
$1.28M 0.02%
4,000
+3,750
+1,500% +$1.28M
FNV icon
283
Franco-Nevada
FNV
$44.6B
$1.23M 0.02%
+20,000
New +$1.07M
VTAE
284
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$1.23M 0.02%
+185,000
New +$1.68M
RKUS
285
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$1.23M 0.02%
125,000
-325,000
-72% -$3M
OTIC
286
DELISTED
Otonomy, Inc.
OTIC
$1.2M 0.02%
+80,100
New +$1.26M
KO icon
287
CALL
Coca-Cola
KO
$374B
$1.18M 0.02%
605,300
+58,800
+11% +$2.56M
KEYW
288
DELISTED
The KEYW Holding Corporation
KEYW
$1.17M 0.02%
176,495
-133,741
-43% -$740K
SCNB
289
DELISTED
Suffolk Bancorp
SCNB
$1.13M 0.02%
44,921
+17,421
+63% +$444K
MRD
290
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
$1.12M 0.02%
+110,000
New +$1.3M
JONE
291
DELISTED
Jones Energy, Inc.
JONE
$1.06M 0.02%
17,372
-15,933
-48% -$713K
VIPS icon
292
Vipshop
VIPS
$7.4B
$1M 0.02%
+77,800
New +$976K
BMRN icon
293
BioMarin Pharmaceuticals
BMRN
$11.9B
$995K 0.02%
+12,062
New +$981K
HTS
294
DELISTED
HATTERAS FINANCIAL CORP
HTS
$994K 0.02%
+69,500
New +$915K
NTES icon
295
NetEase
NTES
$83.5B
$976K 0.02%
+34,000
New +$1.02M
ALNY icon
296
Alnylam Pharmaceuticals
ALNY
$28.9B
$960K 0.02%
+15,292
New +$1.02M
TMUS icon
297
T-Mobile US
TMUS
$193B
$958K 0.02%
25,000
+11,500
+85% +$434K
XENT
298
DELISTED
Intersect ENT, Inc
XENT
$950K 0.02%
50,000
+1,400
+3% +$25.4K
LILA icon
299
Liberty Latin America Class A
LILA
$1.7B
$877K 0.02%
39,045
GM icon
300
PUT
General Motors
GM
$76.3B
$876K 0.02%
+1,390,900
New +$41.8M

Similar funds

UBS O'Connor's Q1 2016 Portfolio in Review

As of Q1 2016, UBS O'Connor held 587 positions worth $5.45B, down 8.3% from $5.94B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

UBS O'Connor deployed $322M of net new capital in Q1 2016, opening 179 new positions and adding to 113 existing holdings. Its largest new stake was BAXALTA INC COM STK (DE): 3,012,562 shares worth $122M.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Nielsen Holdings plc, an estimated $77.1M trimmed.

  • UBS O'Connor's largest Q1 2016 buy was BAXALTA INC COM STK (DE): 3,012,562 shares worth $122M.
  • UBS O'Connor added most to Mondelez International in Q1 2016, an estimated $71M increase.
  • UBS O'Connor's biggest Q1 2016 reduction was Nielsen Holdings plc, cutting an estimated $77.1M.
  • UBS O'Connor fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $496M.
  • UBS O'Connor's ten largest holdings make up 21% of its $5.45B portfolio in Q1 2016.
  • UBS O'Connor opened 179 new positions and closed 156 in Q1 2016.
  • UBS O'Connor's portfolio value fell 8.3% quarter-over-quarter to $5.45B.

Based on UBS O'Connor's 13F filing for Q1 2016, filed 13 May 2016.